Brief: French group Nicox strikes deal with ITROM for 'ZERVIATE' product in Gulf and Arab markets
12/08/2020 06:34
Aug 12 (Reuters) - Nicox SA NCOX.PA :
* Nicox SA, an international ophthalmology company, today
announced the signature of an exclusive license agreement with
ITROM Pharmaceutical Group for the registration and
commercialization of ZERVIATE (TM)(cetirizine ophthalmic
solution), 0.24% for the treatment of ocular itching associated
with allergic conjunctivitis in Gulf and Arab markets including
the Kingdom of Saudi Arabia, the United Arab Emirates and Qatar.
Source text for Eikon: ID:nGNE2F0r2y
Further company coverage: NCOX.PA
(Reporting by Sudip Kar-Gupta)
((sudip.kargupta@thomsonreuters.com;))